Effective interventions for weight management that are low risk, reversible, and applicable to the population who are not candidates for bariatric surgery are appealing. In recent years, the US Food and Drug Administration (FDA) has approved several such devices, with gastric balloon systems being the most widely adopted. As of 2018, it is estimated that gastric balloons comprised 2% of all bariatric procedures.1 At present, gastric balloon systems are FDA-approved for persons with a body mass index (BMI) of 30 to 40 who have been unable to lose weight through diet and exercise and who participate in a multidisciplinary weight loss program.2 Understanding the evidence and areas where further investigation are needed for these devices may help ensure optimal patient care, access, and safety.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Telem DA, Ghaferi AA. Gastric Balloons for Weight Loss in 2020. JAMA. 2020;324(21):2206–2207. doi:10.1001/jama.2020.14862
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: